Home/Publication/Cathay Capital Doubles Down on Life Sciences Supplies
Cathay Capital Doubles Down on Life Sciences Supplies 

23 Feb 2024

US$ 19.00

Cathay Capital has made a follow-on investment in the series A extension financing round of Bio-Link, joined by Haiwang...

Price / article: US$19.00
OR existing subscriber
Related Publications

TPG Inc (TPG) has sold part of its stake in Sai Life Sciences Ltd (Sai Life) and clocked 15 bn rupees (US$173.5 m) in...

TransThera Sciences (Nanjing) Inc (TransThera), a biopharmaceutical company backed by Morningside Ventures and CPE ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.